A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

NCT05349643 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pigmented Villonodular Synovitis
TGCT
Tenosynovial Giant Cell Tumor

Interventions

BIOLOGICAL: AMB-05X

Sponsor

AmMax Bio, Inc.